{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T21:44:35Z","timestamp":1769204675385,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T00:00:00Z","timestamp":1537401600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science KAKENHI","doi-asserted-by":"crossref","award":["15K09717"],"award-info":[{"award-number":["15K09717"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science KAKENHI","doi-asserted-by":"crossref","award":["16K19688"],"award-info":[{"award-number":["16K19688"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science KAKENHI","doi-asserted-by":"crossref","award":["17K16300"],"award-info":[{"award-number":["17K16300"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","pediatr-neonatol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pediatrics & Neonatology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.pedneo.2018.09.005","type":"journal-article","created":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T13:12:47Z","timestamp":1537794767000},"page":"382-388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Chemokine levels predict progressive liver disease in Down syndrome patients with transient abnormal myelopoiesis"],"prefix":"10.1016","volume":"60","author":[{"given":"Tadamune","family":"Kinjo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirosuke","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kusuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Fujiyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Ochiai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Takahata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7550-3118","authenticated-orcid":false,"given":"Satoshi","family":"Honjo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhki","family":"Koga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiro","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shouichi","family":"Ohga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pedneo.2018.09.005_bib1","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1182\/blood-2007-01-069542","article-title":"Incidence and clinical implications of GATA1 mutations in newborns with Down syndrome","volume":"110","author":"Pine","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.pedneo.2018.09.005_bib2","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1182\/blood-2005-06-2448","article-title":"A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): children's Oncology Group (COG) study POG-9481","volume":"107","author":"Massey","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.pedneo.2018.09.005_bib3","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1182\/blood-2007-10-118810","article-title":"Treatment and prognostic impact of transient leukemia in neonates with Down syndrome","volume":"111","author":"Klusmann","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.pedneo.2018.09.005_bib4","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1365-2141.2008.07231.x","article-title":"Risk factors for early death in neonates with Down syndrome and transient leukaemia","volume":"142","author":"Muramatsu","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pedneo.2018.09.005_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00043426-200201000-00004","article-title":"Incidence and treatment of potentially lethal diseases in transient leukemia of Down syndrome: Pediatric Oncology Group Study","volume":"24","author":"Al-Kasim","year":"2002","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.pedneo.2018.09.005_bib6","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1053\/j.gastro.2014.06.043","article-title":"Roles for chemokines in liver disease","volume":"147","author":"Marra","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pedneo.2018.09.005_bib7","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1046\/j.1365-2141.2001.03093.x","article-title":"High expression of platelet-derived growth factor and transforming growth factor-\u03b21 in blast cells from patients with Down Syndrome suffering from transient myeloproliferative disorder and organ fibrosis","volume":"115","author":"Hattori","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pedneo.2018.09.005_bib8","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1600-0609.2008.01061.x","article-title":"Platelet-derived growth factor may be associated with fibrosis in a Down syndrome patient with transient myeloproliferative disorder","volume":"81","author":"Ogawa","year":"2008","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.pedneo.2018.09.005_bib9","doi-asserted-by":"crossref","first-page":"e13787","DOI":"10.5812\/hepatmon.13787","article-title":"Hyaluronic acid: from biochemical characteristics to its clinical translation in assessment of liver fibrosis","volume":"13","author":"Rostami","year":"2013","journal-title":"Hepat Mon"},{"key":"10.1016\/j.pedneo.2018.09.005_bib10","first-page":"220","article-title":"Clinicopathology of sialomucin: MUC1, particularly KL-6 mucin, in gastrointestinal, hepatic and pancreatic cancers","volume":"3","author":"Inagaki","year":"2009","journal-title":"Biosci Trends"},{"key":"10.1016\/j.pedneo.2018.09.005_bib11","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1097\/MPH.0000000000000809","article-title":"Monocyte chemoattractant protein-1 (MCP-1) as a potential therapeutic target and a noninvasive biomarker of liver fibrosis associated with transient myeloproliferative disorder in Down syndrome","volume":"39","author":"Kobayashi","year":"2017","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.pedneo.2018.09.005_bib12","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1182\/blood.V80.6.1521.1521","article-title":"Unusual diffuse liver fibrosis accompanying transient myeloproliferative disorder in Down's syndrome: a report of four autopsy cases and proposal of a hypothesis","volume":"80","author":"Miyauchi","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.pedneo.2018.09.005_bib13","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s12185-013-1487-5","article-title":"Liver disease is frequently observed in Down syndrome patients with transient abnormal myelopoiesis","volume":"99","author":"Park","year":"2014","journal-title":"Int J Hematol"},{"key":"10.1016\/j.pedneo.2018.09.005_bib14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000474930","article-title":"Successful liver transplantation for transient abnormal myelopoiesis-associated liver failure","volume":"112","author":"Yasuoka","year":"2017","journal-title":"Neonatology"},{"key":"10.1016\/j.pedneo.2018.09.005_bib15","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.3109\/10428194.2011.573888","article-title":"Retrospective analysis of risk factors for development of liver dysfunction in transient leukemia of Down syndrome","volume":"52","author":"Hirabayashi","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.pedneo.2018.09.005_bib16","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1159\/000086067","article-title":"Usefulness of the serum KL-6 assay in patients with hepatitis C virus","volume":"48","author":"Arase","year":"2005","journal-title":"Intervirology"},{"key":"10.1016\/j.pedneo.2018.09.005_bib17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3389\/fimmu.2015.00285","article-title":"CXCL8\u2013the first chemokine","volume":"6","author":"Baggiolini","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.pedneo.2018.09.005_bib18","doi-asserted-by":"crossref","first-page":"e21381","DOI":"10.1371\/journal.pone.0021381","article-title":"Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis","volume":"6","author":"Zimmermann","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pedneo.2018.09.005_bib19","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.4049\/jimmunol.1100998","article-title":"Hepatitis B virus induces a novel inflammation network involving three inflammatory factors, IL-29, IL-8, and cyclooxygenase-2","volume":"187","author":"Yu","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.pedneo.2018.09.005_bib20","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jhep.2013.04.011","article-title":"Intrahepatic IL-8 producing Foxp3+ CD4+ regulatory T cells and fibrogenesis in chronic hepatitis C","volume":"59","author":"Langhans","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.pedneo.2018.09.005_bib21","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/jgh.12900","article-title":"Interleukin - 8: a critical chemokine in biliary atresia","volume":"30","author":"Dong","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.pedneo.2018.09.005_bib22","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/hep.23338","article-title":"Chemokine (C-C motif) receptors in fibrogenesis and hepatic regeneration following acute and chronic liver disease","volume":"50","author":"Ramm","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.pedneo.2018.09.005_bib23","first-page":"423","article-title":"Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration","volume":"152","author":"Marra","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pedneo.2018.09.005_bib24","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2174\/187152809789352230","article-title":"Monocytes and macrophages as cellular targets in liver fibrosis","volume":"8","author":"Heymann","year":"2009","journal-title":"Inflamm Allergy Drug Targets"},{"key":"10.1016\/j.pedneo.2018.09.005_bib25","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1172\/JCI116753","article-title":"Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines","volume":"92","author":"Marra","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pedneo.2018.09.005_bib26","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.leukres.2006.09.008","article-title":"Pro-inflammatory cytokinemia is frequently found in Down syndrome patients with hematological disorders","volume":"31","author":"Shimada","year":"2007","journal-title":"Leuk Res"},{"key":"10.1016\/j.pedneo.2018.09.005_bib27","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/0046-8177(91)90111-2","article-title":"Severe perinatal liver disease and Down syndrome: an apparent relationship","volume":"22","author":"Ruchelli","year":"1991","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pedneo.2018.09.005_bib28","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s00134-002-1305-7","article-title":"Transient abnormal myelopoiesis (TAM) causing multiple organ failure","volume":"28","author":"Hoskote","year":"2002","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.pedneo.2018.09.005_bib29","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1097\/MPH.0b013e3181d74732","article-title":"Cytokine profiles before and after exchange transfusion in a neonate with transient myeloproliferative disorder and hepatic fibrosis","volume":"32","author":"Sugiura","year":"2010","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.pedneo.2018.09.005_bib30","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1097\/MPH.0b013e31822bf608","article-title":"Improving circulatory disturbance in transient abnormal myelopoiesis","volume":"34","author":"Koga","year":"2012","journal-title":"J Pediatr Hematol Oncol"}],"container-title":["Pediatrics & Neonatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875957218301281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875957218301281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T15:33:51Z","timestamp":1571931231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875957218301281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S1875957218301281"],"URL":"https:\/\/doi.org\/10.1016\/j.pedneo.2018.09.005","relation":{},"ISSN":["1875-9572"],"issn-type":[{"value":"1875-9572","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemokine levels predict progressive liver disease in Down syndrome patients with transient abnormal myelopoiesis","name":"articletitle","label":"Article Title"},{"value":"Pediatrics & Neonatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pedneo.2018.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Taiwan Pediatric Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}